Patents
Patents for C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
09/2002
09/04/2002EP1236720A1 Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors
09/04/2002EP1141140B1 Naphthalenehydrazamimides and perylenehydrazamimides
08/2002
08/29/2002WO2002066437A1 Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone
08/29/2002WO2002066431A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
08/29/2002WO2002000622A3 Aminoalcohol derivatives
08/29/2002WO2001087845A3 N-containing heterocyclic compounds and their use as 5-ht antagonists
08/29/2002CA2438709A1 Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone
08/29/2002CA2432208A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
08/28/2002EP1234827A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
08/28/2002EP1234826A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
08/28/2002EP1234825A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
08/28/2002EP1234824A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
08/28/2002EP1234823A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
08/28/2002EP0892804B1 Isoxazolidine derivatives
08/27/2002US6441193 Intermediates such as 1-(2-(4-(6-methoxy-3,4-dihydronaphtha-len-1-yl)phenoxy)ethyl)pyrrolidine and compounds such as cis-6-phenyl-5-(4-(2-pyrrolidin-1-ylethoxy)phenyl)-5,6,7,8 -tetrahydronaphthalen-2-ol, hydrobromide salt
08/27/2002US6441176 Method for preparing sodium-hydrogen exchanger type 1 inhibitor
08/27/2002US6441171 Method for the production of 4,6-dichloropyrimidine with the aid of phosgene
08/27/2002US6440969 Certain isoquinolinamine and phthalazinamine derivatives: corticotropin-releasing factor receptor CRF1 specific ligands
08/27/2002US6440968 Use of maduraohtalazine derivatives as inhibitors of proinflammatory cytokines
08/27/2002US6440440 Biocidal benzylbiphenyl derivatives
08/22/2002WO2002064584A1 Phthalayinone-piperidino-derivatives as pde4 inhibitors
08/22/2002WO2002064546A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
08/22/2002WO2002064545A1 Acylated indanyl amines and their use as pharmaceuticals
08/22/2002US20020115663 Novel compounds
08/22/2002DE10108271A1 Chinolin-, Isochinolin- und Phthalazinderivate als Antagonisten des Gonadotropin freisetzenden Hormons Quinoline, isoquinoline and phthalazine derivatives releasing as antagonists of gonadotropin hormone
08/21/2002EP1231982A2 Use of phthalazine derivatives
08/15/2002US20020111356 Phosphodiesterase inhibitor; antiinflammatory agents
08/14/2002CN1089086C Luminide and macroluminide class of pharmaceuticals
08/08/2002WO2002060858A1 Novel compound having maillard reaction inhibitory activity
08/07/2002EP1228069A2 Bicyclic and tricyclic heteroaromatic compounds
08/07/2002EP1228063A2 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
08/07/2002EP1228046A1 Phthalazinone derivatives as pde 4 inhibitors
08/07/2002EP1228045A2 Heterocyclic cytotoxic agents
08/07/2002EP0638112B1 Liquid crystal compounds having perfluoroether terminal portions
08/07/2002CN1088700C Novel chemical hybridization agent
08/01/2002US20020103203 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
07/2002
07/31/2002EP1226127A2 Uracil substituted phenyl sulfamoyl carboxamides
07/31/2002EP0934255B1 Production of pyridazine herbicides
07/30/2002US6426415 Polyadenosine 5'-diphospho-ribose polymerase (parp) enzyme inhibitors, alkoxy substituted n-heterocycle derivatives
07/30/2002US6426349 Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes for neoplasia
07/25/2002WO2002057236A1 Phenyl derivatives
07/25/2002WO2002015884A3 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor
07/25/2002DE10102322A1 New disubstituted and trisubstituted benzene derivatives useful as coagulation inhibitors for the treatment of thromboembolic diseases
07/24/2002EP0988045A4 Peptide nucleic acid monomers and oligomers
07/24/2002CN1360581A Benzoylpyridazines
07/24/2002CN1360580A Substd. benzoyl ketones, methods for producing them and their use as herbicides
07/18/2002WO2002055501A2 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
07/18/2002CA2434274A1 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
07/17/2002CN1359376A Carboxylic acid derivatives compriosing aryl-substituted nitrogen heterocycles, their production and their use as endothel in receptor antagonists
07/11/2002US20020091089 (Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases
07/10/2002CN1358176A Method for producing 2-heterocyclyl methyl benzoic acid derivatives
07/10/2002CN1358173A Heterocyclic dicarboxylic acid diamide derivatives, agricul-horticul tural insecticides and method of using the same
07/09/2002US6417189 Drugs with pyrazole ketone derivatives
07/09/2002US6417188 Arylalkanoylpyridazines
07/04/2002WO2002051814A1 Benzoylpyridazines
07/04/2002WO2002005848A3 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
07/04/2002WO2001064652A9 Substituted 5-methyldihydropyridazinones and their use in the prophylaxis and/or treatment of anemias
07/04/2002DE10063294A1 New N-(heterocyclyl-alkyl)-fused norbornylamine derivatives, are NHE3 inhibitors useful e.g. for treating respiratory disorders, renal failure, intestinal dysfunction, lipid metabolism disorders or proliferative diseases
07/02/2002US6413966 Serotonergic and central dopaminergic activity; affinity for 5ht1a and 5ht2 serotonin and d2 dopamine receptors; atypical antipsychotics; schizophrenia
06/2002
06/27/2002WO2002050045A1 Antiviral agents
06/27/2002WO2002024613A3 Resorcinol derivatives
06/27/2002WO2002010154A3 Substituted heterocyclic amides
06/27/2002CA2431483A1 Antiviral agents
06/26/2002EP1216240A1 Amide compounds
06/26/2002CN1355702A Use of arylalkanoylpyridazines
06/20/2002WO2000067734A3 Use of phthalazine derivatives
06/19/2002EP1214317A1 Antiviral agents
06/18/2002US6407108 1,2,4-triazolo(4,3-b)pyrido(3,2-d)pyridazine derivatives and pharmaceutical compositions containing them
06/18/2002CA1341370C Fused polycyclic compounds, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents
06/13/2002WO2002046161A1 Substituted carboxylic acid derivatives
06/13/2002US20020071857 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor
06/13/2002CA2430846A1 Substituted carboxylic acid derivatives
06/12/2002EP1212328A1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
06/11/2002US6403587 Autoimmune diseases, acute and chronic inflammatory conditions, allergic conditions, infection associated with inflammation, viral, transplantation tissue rejection, atherosclerosis, restenosis, hiv infectivity, and
06/11/2002US6403586 Interleukin inhibitors
06/06/2002WO2002044157A2 Parb inhibitors
06/06/2002US20020068746 Pyrrolo[2,3-d]pyrimidine compounds
06/06/2002US20020068734 Nitrogen-containing heterocyclic compounds
06/05/2002EP1210333A2 Novel herbicides
06/05/2002EP0711282B1 Compounds as pde iv and tnf inhibitors
06/04/2002US6399611 2-(4-ethoxycarbonylaminobenzyl)-6-(3,4 -dimethoxyphenyl)-2,3,4, 5-tetrahydropyridazin-3-one or alternately benzyl substituted compounds; phosphodiesterase iv and tumour necrosis factor inhibitors
06/04/2002US6399610 Nasal or oral treatment of heart failure; reduced occurance of headaches or palpitation
05/2002
05/30/2002WO2002042257A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
05/30/2002WO2001046194A3 Process for the preparation of pyrazolo[1,5-b]pyridazine derivatives
05/30/2002CA2429328A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
05/29/2002CN1351592A Acyl derivatives which treat VL4-4 related disorders
05/29/2002CN1085663C Aromatic amino ethers as pain relieving agents
05/28/2002US6395896 Pyridazine derivatives, manufacturing method and related composition
05/28/2002US6395731 Anticoagulants
05/23/2002WO2002040025A1 Anti-inflammatory agents
05/23/2002WO2001083458A3 Asymmetric synthesis of piperazic acid and derivatives thereof
05/16/2002WO2002018339A3 Compounds useful as insecticides, compounds useful as acaricides, and processes to use and make same
05/16/2002WO2001083459A3 Uracil substituted phenyl sulfamoyl carboxamides
05/16/2002US20020058662 Phthalazine derivatives as phosphodiesterase 4 inhibitors
05/15/2002EP1204647A1 Method for the production of 4,6-dichloropyrimidine with the aid of phosgene
05/15/2002CN1349519A Glucokinase activators
05/15/2002CN1084736C Substituted bheterocyclic carboxamide esters, their prepn. and their use as pharmaceuticals
05/14/2002US6387949 Substituted urea compounds useful in pain management
05/14/2002CA2105067C Indan derivative and thromboxane antagonist containing the same
05/10/2002WO2002036576A1 Phthalazinone derivatives
1 ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 ... 85